Sana Biotechnology
Sana Biotechnology develops engineered cell and gene therapies to repair, control, or replace cells in order to address the underlying causes of diseases such as diabetes, B-cell cancers, and B-cell related autoimmune disorders. Its mission is to create novel medicines that meaningfully improve patient outcomes and broaden access to transformative treatments.
Facts
- Sectors
- Biotechnology, Gene editing, Cell therapy, Biopharmaceuticals
- Founded
- 2018 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Sana Biotechnology Inc Seattle business license
- Stage
- Public
- Members see funding amounts. .
Is this your organization? Claim it
'They proved me wrong.' Investor who passed on Seattle startup analyzes its IPO
Jason Stoffer was still early in his career at venture capital firm Maveron in 2012 when he declined an opportunity to invest in Remitly, then a fledgling Seattle startup with ambitions to challenge Western Union by bringing a tech mindset to the business of international money transfers. He was impressed by Remitly co-founders Matt Oppenheimer and Josh Hug but knew they faced a huge challenge in getting the state-by-state regulatory approval required to make monetary remittances to what was then their initial international market, the Philippines. "It felt like the end vision was powerful — if they can get there,"…
How SPACs are shaking up Seattle's startup scene
An online marketplace that helps to facilitate trade between marijuana sellers and buyers will soon see its own stock traded on the Nasdaq. Another that connects pet owners with walkers, boarders and other caregivers just posted its first earnings as a publicly traded company. And a 3-year-old Redmond-based biotech company with a mere 25 employees just raised $80 million its stock market debut. SPACs are shaking up Seattle's startup scene. On this episode of the GeekWire Podcast, we examine how special purpose acquisition companies are turning startups into publicly traded stocks at a rapid clip. The SPAC phenomenon is giving…
People
-
Steve Harr Co-founder and President and Chief Executive Officer
-
Snehal Patel Executive, Executive Vice President and Chief Technical Officer